These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 23277274)

  • 1. Inhibition of farnesyl pyrophosphate synthase attenuates angiotensin II-induced cardiac hypertrophy and fibrosis in vivo.
    Yang J; Zhu HH; Chen GP; Ye Y; Zhao CZ; Mou Y; Hu SJ
    Int J Biochem Cell Biol; 2013 Mar; 45(3):657-66. PubMed ID: 23277274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac-specific overexpression of farnesyl pyrophosphate synthase induces cardiac hypertrophy and dysfunction in mice.
    Yang J; Mou Y; Wu T; Ye Y; Jiang JC; Zhao CZ; Zhu HH; Du CQ; Zhou L; Hu SJ
    Cardiovasc Res; 2013 Mar; 97(3):490-9. PubMed ID: 23180723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Knockdown of farnesylpyrophosphate synthase prevents angiotensin II-mediated cardiac hypertrophy.
    Ye Y; Mou Y; Bai B; Li L; Chen GP; Hu SJ
    Int J Biochem Cell Biol; 2010 Dec; 42(12):2056-64. PubMed ID: 20884373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of farnesyl pyrophosphate synthase prevents angiotensin II-induced cardiac fibrosis in vitro.
    Li Z; Bi X; Wang M; Zhang J; Song J; Shen X; Han J; Fu G; Ye Y
    Clin Exp Immunol; 2014 Jun; 176(3):429-37. PubMed ID: 24527834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic inhibition of farnesyl pyrophosphate synthase attenuates cardiac hypertrophy and fibrosis in spontaneously hypertensive rats.
    Li L; Chen GP; Yang Y; Ye Y; Yao L; Hu SJ
    Biochem Pharmacol; 2010 Feb; 79(3):399-406. PubMed ID: 19800872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of farnesyl pyrophosphate synthase attenuates angiotensin II-induced fibrotic responses in vascular smooth muscle cells.
    Du CQ; Liu XW; Zeng GZ; Jin HF; Tang LJ
    Int J Mol Med; 2015 Jun; 35(6):1767-72. PubMed ID: 25847782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alteration of RhoA Prenylation Ameliorates Cardiac and Vascular Remodeling in Spontaneously Hypertensive Rats.
    Yang J; Chen YN; Xu ZX; Mou Y; Zheng LR
    Cell Physiol Biochem; 2016; 39(1):229-41. PubMed ID: 27336844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Klotho inhibits angiotensin II-induced cardiac hypertrophy, fibrosis, and dysfunction in mice through suppression of transforming growth factor-β1 signaling pathway.
    Ding J; Tang Q; Luo B; Zhang L; Lin L; Han L; Hao M; Li M; Yu L; Li M
    Eur J Pharmacol; 2019 Sep; 859():172549. PubMed ID: 31325434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of farnesyl pyrophosphate synthase improves pressure overload induced chronic cardiac remodeling.
    Zhao CZ; Zhao XM; Yang J; Mou Y; Chen B; Wu HD; Dai DP; Ding J; Hu SJ
    Sci Rep; 2016 Dec; 6():39186. PubMed ID: 28008986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of myofibrillogenesis regulator-1 aggravates cardiac hypertrophy induced by angiotensin II in mice.
    Li HL; She ZG; Li TB; Wang AB; Yang Q; Wei YS; Wang YG; Liu DP
    Hypertension; 2007 Jun; 49(6):1399-408. PubMed ID: 17420335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. B-type natriuretic peptide attenuates cardiac hypertrophy via the transforming growth factor-ß1/smad7 pathway in vivo and in vitro.
    He JG; Chen YL; Chen BL; Huang YY; Yao FJ; Chen SL; Dong YG
    Clin Exp Pharmacol Physiol; 2010 Mar; 37(3):283-9. PubMed ID: 19719752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kaempferol Alleviates Angiotensin II-Induced Cardiac Dysfunction and Interstitial Fibrosis in Mice.
    Liu Y; Gao L; Guo S; Liu Y; Zhao X; Li R; Yan X; Li Y; Wang S; Niu X; Yao L; Zhang Y; Li L; Yang H
    Cell Physiol Biochem; 2017; 43(6):2253-2263. PubMed ID: 29073623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Knock-down of farnesyl pyrophosphate synthase protects heart-derived H9c2 cells against hypoxia/reoxygenation-induced injury.
    Dai D; Wu H; Yang J; Shen S; Zhao C; Ding J; Hu S
    Cell Biol Int; 2017 Sep; 41(9):982-990. PubMed ID: 28544034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective effects of endogenous adrenomedullin on cardiac hypertrophy, fibrosis, and renal damage.
    Niu P; Shindo T; Iwata H; Iimuro S; Takeda N; Zhang Y; Ebihara A; Suematsu Y; Kangawa K; Hirata Y; Nagai R
    Circulation; 2004 Apr; 109(14):1789-94. PubMed ID: 14967720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of farnesylpyrophosphate synthase prevents angiotensin II-induced hypertrophic responses in rat neonatal cardiomyocytes: involvement of the RhoA/Rho kinase pathway.
    Ye Y; Hu SJ; Li L
    FEBS Lett; 2009 Sep; 583(18):2997-3003. PubMed ID: 19716825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin II-induced pro-fibrotic effects require p38MAPK activity and transforming growth factor beta 1 expression in skeletal muscle cells.
    Morales MG; Vazquez Y; Acuña MJ; Rivera JC; Simon F; Salas JD; Alvarez Ruf J; Brandan E; Cabello-Verrugio C
    Int J Biochem Cell Biol; 2012 Nov; 44(11):1993-2002. PubMed ID: 22964022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heparin cofactor II protects against angiotensin II-induced cardiac remodeling via attenuation of oxidative stress in mice.
    Sumitomo-Ueda Y; Aihara K; Ise T; Yoshida S; Ikeda Y; Uemoto R; Yagi S; Iwase T; Ishikawa K; Hirata Y; Akaike M; Sata M; Kato S; Matsumoto T
    Hypertension; 2010 Sep; 56(3):430-6. PubMed ID: 20660821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin II increases CTGF expression via MAPKs/TGF-β1/TRAF6 pathway in atrial fibroblasts.
    Gu J; Liu X; Wang QX; Tan HW; Guo M; Jiang WF; Zhou L
    Exp Cell Res; 2012 Oct; 318(16):2105-15. PubMed ID: 22749815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD38 promotes angiotensin II-induced cardiac hypertrophy.
    Guan XH; Hong X; Zhao N; Liu XH; Xiao YF; Chen TT; Deng LB; Wang XL; Wang JB; Ji GJ; Fu M; Deng KY; Xin HB
    J Cell Mol Med; 2017 Aug; 21(8):1492-1502. PubMed ID: 28296029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The antifibrotic agent pirfenidone inhibits angiotensin II-induced cardiac hypertrophy in mice.
    Yamazaki T; Yamashita N; Izumi Y; Nakamura Y; Shiota M; Hanatani A; Shimada K; Muro T; Iwao H; Yoshiyama M
    Hypertens Res; 2012 Jan; 35(1):34-40. PubMed ID: 21866107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.